Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative

Roth, Arnaud

doi:10.1016/j.ejca.2014.10.027

Scientific article

Review

English

Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative

ContributorsRoth, Arnaud

Published inEuropean journal of cancer, vol. 51, no. 3, p. 271-281

Publication date2015

Abstract

The past three decades have seen rapid improvements in the diagnosis and treatment of most cancers and the most important contributor has been research. Progress in rare cancers has been slower, not least because of the challenges of undertaking research.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Groupe Roth Arnaud (oncologie) (285)

Citation (ISO format)

ROTH, Arnaud. Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative. In: European journal of cancer, 2015, vol. 51, n° 3, p. 271–281. doi: 10.1016/j.ejca.2014.10.027

Article (Published version)

Identifiers

PID : unige:48102
DOI : 10.1016/j.ejca.2014.10.027
PMID : 25542058

Journal ISSN0959-8049

607views

343downloads

Creation10/03/2015 15:19:00

First validation10/03/2015 15:19:00

Update14/03/2023 23:00:58

Status update14/03/2023 23:00:58

Last indexation30/10/2024 23:28:53

Archive ouverte UNIGE

Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative

The past three decades have seen rapid improvements in the diagnosis and treatment of most cancers and the most important contributor has been research. Progress in rare cancers has been slower, not least because of the challenges of undertaking research.

Technical informations